Identification of a dominant epitope in human vaccinia-related kinase 1 (VRK1) and detection of different intracellular subpopulations

被引:44
|
作者
Valbuena, Alberto
Lopez-Sanchez, Inmaculada
Vega, Francisco M.
Sevilla, Ana
Sanz-Garcia, Marta
Blanco, Sandra
Lazo, Pedro A.
机构
[1] Univ Salamanca, CSIC, Ctr Invest Canc, Inst Biol Mol & Celular Canc, E-37007 Salamanca, Spain
[2] Univ Salamanca, CSIC, Ctr Invest Canc, Programa Oncol Translac, E-37007 Salamanca, Spain
关键词
VRK1; antibody; epitopes; immunohistochemistry; subcellular localization;
D O I
10.1016/j.abb.2007.06.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human VRK1 is a new ser-thr kinase expressed in many cell types. VRK1 is a regulator of p53 and other transcription factors related with cellular responses to stress. The human VRK1 protein has a dominant epitope located in its C-terminal region, between residues 333 and 396, which is detected by different antibodies. All the antibodies detect the same protein in immunoblots and immunoprecipitations. But the antibodies have a different reactivity when a single aminoacid substitution in T355, mimicking phosphorylation, is introduced next to the nuclear localization signal. These differences in reactivity permit the identification of different intracellular subpopulations. Most of the intracellular VRK1 protein is nuclear, but in some cells it is also detected in the cytosol, depending on the type of tissue. These different locations are detected by immunohistochemistry of human biopsies and immunofluorescence of cell lines. Some antibodies identify a subpopulation within the vesicular system, particularly in the Golgi apparatus. The different reactivity of the VRK1 protein indicates that this protein has a subcellular localization that can be regulated, thus adding an additional level of regulatory complexity to the VRK1 protein. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:219 / 226
页数:8
相关论文
共 50 条
  • [1] Human vaccinia-related kinase 1 (VRK1) regulation and its implication in cell proliferation
    Valbuena, A.
    Lazo, P. A.
    FEBS JOURNAL, 2007, 274 : 155 - 155
  • [2] Proteomics Identification of Nuclear Ran GTPase as an Inhibitor of Human VRK1 and VRK2 (Vaccinia-related Kinase) Activities
    Sanz-Garcia, Marta
    Lopez-Sanchez, Inmaculada
    Lazo, Pedro A.
    MOLECULAR & CELLULAR PROTEOMICS, 2008, 7 (11) : 2199 - 2214
  • [3] Investigation of Disease-Causing Point Variants of Vaccinia-Related Kinase 1 (VRK1)
    Frederick, McKinzie M.
    Mai, Elissa N.
    Hurley, David P.
    Schoeneman, Laura L.
    Ruff, Emily F.
    FASEB JOURNAL, 2022, 36
  • [4] Backbone 1H, 13C and 15N resonance assignments of human vaccinia-related kinase 1 (VRK1)
    Joon Shin
    Goutam Chakraborty
    Ho Sup Yoon
    Biomolecular NMR Assignments, 2014, 8 : 29 - 31
  • [5] Backbone 1H, 13C and 15N resonance assignments of human vaccinia-related kinase 1 (VRK1)
    Shin, Joon
    Chakraborty, Goutam
    Yoon, Ho Sup
    BIOMOLECULAR NMR ASSIGNMENTS, 2014, 8 (01) : 29 - 31
  • [6] Mitogen activated kinase phosphatase 2 (MKP2) regulates of vaccinia-related kinase 1 (VRK1) independent of phosphatase activity
    Jeong, M. -W.
    Kim, W.
    Choi, Y. H.
    Kim, K. -T.
    Kim, S. -J.
    FEBS JOURNAL, 2012, 279 : 346 - 346
  • [7] c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK)
    Sevilla, A
    Santos, CR
    Barcia, R
    Vega, FM
    Lazo, PA
    ONCOGENE, 2004, 23 (55) : 8950 - 8958
  • [8] Vaccinia-related kinase 1 (VRK1) confers resistance to DNA-damaging agents in human breast cancer by affecting DNA damage response
    Salzano, Marcella
    Vazquez-Cedeira, Marta
    Sanz-Garcia, Marta
    Valbuena, Alberto
    Blanco, Sandra
    Fernandez, Isabel F.
    Lazo, Pedro A.
    ONCOTARGET, 2014, 5 (07) : 1770 - 1778
  • [9] c-Jun phosphorylation by the human vaccinia-related kinase 1 (VRK1) and its cooperation with the N-terminal kinase of c-Jun (JNK)
    Ana Sevilla
    Claudio R Santos
    Ramiro Barcia
    Francisco M Vega
    Pedro A Lazo
    Oncogene, 2004, 23 : 8950 - 8958
  • [10] NMR Solution Structure of Human Vaccinia-related Kinase 1 (VRK1) Reveals the C-terminal Tail Essential for Its Structural Stability and Autocatalytic Activity
    Shin, Joon
    Chakraborty, Goutam
    Bharatham, Nagakumar
    Kang, CongBao
    Tochio, Naoya
    Koshiba, Seizo
    Kigawa, Takanori
    Kim, Wanil
    Kim, Kyong-Tai
    Yoon, Ho Sup
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (25) : 22131 - 22138